Cambridge Healthtech Institute’s 10th Annual
Advances in Immunotherapy
Harnessing the Power of the Immune System
May 12-13, 2025
Cambridge Healthtech Institute’s 10th Annual Advances in Immunotherapy conference explores the latest developments in understanding and enhancing the immune system to fight cancer and autoimmune disease. Key topics include: new targets and mechanisms for anti-cancer immunity, overcoming the tumor microenvironment, targeting solid tumors and mechanisms, the trend towards autoimmune, (re)emerging modalities such as agonists, immune cell engagers, AI/ML in immunotherapy—plus effective strategies to improve immunotherapy safety and efficacy. Examples will come from the worlds of biotherapeutics, proteins, cell-based therapies, and more.
Coverage will include, but is not limited to:
- Latest advances in immunotherapy for cancer and autoimmune disorders
- Overcoming the TME
- Targeting solid tumors
- TCR-based therapies and intracellular targeting
- Advances in TCR biology and screening
- Immune modulators
- Immune cell engagers
- Agonists—new targets, next-generation approaches, what have we learned
- Sting, TLRs
- AI/ML approaches to advancing immunotherapy
- Screening for new targets
- Engineered cytokines
- Glycobiology and engineering
- Improving patient response to immunotherapies
- Mitigating toxicity and resistance
- Bacterial immunotherapy; engineering bacteria to enable immunotherapy
The deadline for priority consideration is October 11, 2024.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: